CRSP logo

CRISPR Therapeutics AG (CRSP)

Profile

Full Name

CRISPR Therapeutics AG

Ticker Symbol

CRSP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

October 19, 2016

Indexes

Not included

Website

http://www.crisprtx.com

Employees

393

Key Details

Price

$38.25(+11.65%)

Market cap

$3.28B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$35.00M(-90.54% YoY)

Annual EPS

-$4.34(-123.71% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$38.25
CRSP price is $38.25

30-Day Relative Volume

1.55
CRSP 30-day relative volume is 1.55

Price Performance

Price Today change

+11.65%
CRSP price is up +11.65% today

Price YTD change

-2.82%
CRSP price is down -2.82% since January 1st

Price 1-year change

-39.2%
CRSP price is down -39.2% year-on-year

Price 3-year change

-37.75%
CRSP price is down -37.75% over the past 3 years

Price Range

Price All-time high

$220.20
CRSP price is currently -82.63% below its historical high of $220.20

Price 3-year low

$30.04
CRSP price is currently +27.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.28B
CRSP market capitalization is $3.28 billion

Market cap 3-year change

-31.01%
CRSP market capitalization is down -31.01% over the past 3 years

Market cap All-time high

$15.53B
CRSP market capitalization is currently -78.87% below its historical high of $15.53 billion

Market cap sector rank

87.51%
CRSP market capitalization is higher than 87.51% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.05%
CRSP shares outstanding is up +1.05% year-on-year

Shares Outstanding 3-Year Change

+10.84%
CRSP shares outstanding is up +10.84% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.25
CRSP beta is 1.25

200-day SMA

$46.50
CRSP price is currently -17.74% below its 200-day simple moving average

50-day SMA

$41.32
CRSP price is currently -7.42% below its 50-day simple moving average

RSI

39.51
CRSP 14-day relative strength index is 39.51

Volume

1.55
CRSP 30-day relative volume is 1.55

ATR

$2.50
CRSP average true range is $2.50

10-day Historical Volatility

83.65%
CRSP 10-day historical volatility is 83.65%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$35.00M
CRSP annual revenue is $35.00 million

Revenue Analysts estimate

$61.77M
CRSP annual revenue is currently -43.34% lower than the consensus analysts' forecast

Revenue 1-year change

-90.54%
CRSP annual revenue is down -90.54% year-on-year

Revenue Sector rank

42.11%
CRSP annual revenue is higher than 42.11% of companies in Healthcare sector

EPS

EPS

-$4.34
CRSP annual earnings per share is -$4.34

EPS Analysts estimate

-$4.82
CRSP annual earnings per share is currently -10.00% lower than the consensus analysts' forecast

EPS 1-year change

-123.71%
CRSP annual earnings per share is down -123.71% year-on-year

EPS Sector rank

21.47%
CRSP annual earnings per share is higher than 21.47% of companies in Healthcare sector

Profit

Gross profit

-$75.25M
CRSP annual gross profit is -$75.25 million

Gross margin

-215.00%
CRSP annual gross profit margin is -215.00%

Operating profit

-$466.57M
CRSP annual operating income is -$466.57 million

Operating margin

-1333.05%
CRSP annual operating profit margin is -1333.05%

Net income

-$366.25M
CRSP annual net profit is -$366.25 million

Net margin

-1046.43%
CRSP annual net profit margin is -1046.43%

Expenses

Total expenses

$501.57M
CRSP annual total expenses is $501.57 million

Operating expenses

$391.32M
CRSP annual total operating expenses is $391.32 million

Cost of goods sold

$110.25M
CRSP annual cost of goods sold is $110.25 million

Selling, general & administrative expenses

$72.98M
CRSP annual SGA is $72.98 million

Depreciation and amortization

$19.26M
CRSP annual depreciation & amortization is $19.26 million

Interest expense

-
CRSP annual interest expense value is unknown

Income tax

$3.59M
CRSP annual income tax is $3.59 million

EBIT & EBITDA

EBIT

-$466.57M
CRSP annual earnings before interest & taxes is -$466.57 million

EBITDA

-$447.31M
CRSP annual EBITDA is -$447.31 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.24B
CRSP annual total assets is $2.24 billion

Non current assets

$304.90M
CRSP annual long term assets is $304.90 million

Current assets

$1.94B
CRSP annual total current assets is $1.94 billion

Cash and cash equivalents

$298.26M
CRSP annual cash & cash equivalents is $298.26 million

Accounts receivable

$25.00M
CRSP annual accounts receivable is $25.00 million

Inventory

-
CRSP annual inventory value is unknown

Liabilities

Total liabilities

$309.95M
CRSP annual total liabilities is $309.95 million

Long term liabilities

$222.17M
CRSP annual total long term liabilities is $222.17 million

Current liabilities

$87.78M
CRSP annual total current liabilities is $87.78 million

Accounts payable

$14.71M
CRSP annual accounts payable is $14.71 million

Debt

Total debt

$223.69M
CRSP annual total debt is $223.69 million

Total debt 1-year change

-6.26%
CRSP annual total debt is down -6.26% year-on-year

Long term debt

$206.41M
CRSP annual long term debt is $206.41 million

Short term debt

$17.29M
CRSP annual short term debt is $17.29 million

Equity & Capital

Shareholders equity

$1.93B
CRSP annual stockholders equity is $1.93 billion

Book value

$1.93B
CRSP annual book value is $1.93 billion

Retained earnings

-$1.37B
CRSP annual retained earnings is -$1.37 billion

Working capital

$1.85B
CRSP annual working capital is $1.85 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$142.77M
CRSP annual cash flow from operations is -$142.77 million

Cash from operations 1-year change

+45.17%
CRSP annual cash flow from operations is up +45.17% year-on-year

Cash from investing

-$280.48M
CRSP annual cash flow from investing activities is -$280.48 million

Cash from investing 1-year change

-174.87%
CRSP annual cash flow from investing activities is down -174.87% year-on-year

Cash from financing

$331.98M
CRSP annual cash flow from financing activities is $331.98 million

Cash from financing 1-year change

+429.78%
CRSP annual cash flow from financing activities is up +429.78% year-on-year

CAPEX

CAPEX

$1.90M
CRSP annual capital expenditures is $1.90 million

CAPEX 1-year change

-84.12%
CRSP annual capital expenditures is down -84.12% year-on-year

Free Cash Flow

Free cash flow

-$144.68M
CRSP annual free cash flow is -$144.68 million

Free cash flow 1-year change

+46.88%
CRSP annual free cash flow is up +46.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-215.00%
CRSP annual gross profit margin is -215.00%

Operating margin

-1333.05%
CRSP annual operating profit margin is -1333.05%

Net margin

-1046.43%
CRSP annual net profit margin is -1046.43%

ROA & ROE

ROA

-16.38%
CRSP annual return on assets is -16.38%

ROE

-19.20%
CRSP annual return on equity is -19.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRSP price to earnings ratio value is unknown

PE ratio Sector rank

-
CRSP price to earnings ratio is unknown

PB Ratio

PB ratio

1.70
CRSP price to book ratio is 1.70

PB ratio Sector rank

59.13%
CRSP price to book ratio is higher than 59.13% of companies in Healthcare sector

PS Ratio

PS ratio

93.74
CRSP price to sales ratio is 93.74

PS ratio Sector rank

94.87%
CRSP price to sales ratio is higher than 94.87% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.21B
CRSP enterprise value is $3.21 billion

Enterprise value Sector rank

85.9%
CRSP enterprise value is higher than 85.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.17
CRSP EV/EBITDA is -7.17

EV/EBITDA Sector rank

13.98%
CRSP EV/EBITDA is higher than 13.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

22.07
CRSP annual current ratio is 22.07

Quick ratio

-
CRSP annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CRSP annual debt to equity ratio is 0.00

Interest coverage ratio

-
CRSP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRSP piotroski f-score value is unknown

Altman Z-Score

5.82
CRSP altman z-score is 5.82

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Feb 19, 25 Cantor Fitzgerald
Neutral
Feb 18, 25 Citigroup
Buy
Feb 14, 25 Morgan Stanley
Underweight
Feb 14, 25 Evercore ISI Group
Outperform
Feb 13, 25 Stifel
Hold
Feb 13, 25 JMP Securities
Market Outperform
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Goldman Sachs
Neutral
Feb 13, 25 Chardan Capital
Buy

Institutional Ownership

Similar stocks

OGN logo
Organon & Co (OGN)
HAE logo
Haemonetics (HAE)
RNA logo
Avidity Biosciences (RNA)
SLNO logo
Soleno Therapeutics (SLNO)
AMED logo
Amedisys (AMED)
SHC logo
Sotera Health (SHC)
PRVA logo
Privia Health (PRVA)
BTSG logo
BrightSpring Health Services (BTSG)
RARE logo
Ultragenyx Pharmaceutical (RARE)
  • What is the ticker symbol for CRISPR Therapeutics AG?
  • Does CRISPR Therapeutics AG pay dividends?
  • What sector is CRISPR Therapeutics AG in?
  • What industry is CRISPR Therapeutics AG in?
  • What country is CRISPR Therapeutics AG based in?
  • When did CRISPR Therapeutics AG go public?
  • Is CRISPR Therapeutics AG in the S&P 500?
  • Is CRISPR Therapeutics AG in the NASDAQ 100?
  • Is CRISPR Therapeutics AG in the Dow Jones?
  • When was CRISPR Therapeutics AG's last earnings report?
  • When does CRISPR Therapeutics AG report earnings?
  • Should I buy CRISPR Therapeutics AG stock now?

What is the ticker symbol for CRISPR Therapeutics AG?

The ticker symbol for CRISPR Therapeutics AG is NASDAQ:CRSP

Does CRISPR Therapeutics AG pay dividends?

No, CRISPR Therapeutics AG does not pay dividends

What sector is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG is in the Healthcare sector

What industry is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG is in the Biotechnology industry

What country is CRISPR Therapeutics AG based in?

CRISPR Therapeutics AG is headquartered in Switzerland

When did CRISPR Therapeutics AG go public?

CRISPR Therapeutics AG's initial public offering (IPO) was on October 19, 2016

Is CRISPR Therapeutics AG in the S&P 500?

No, CRISPR Therapeutics AG is not included in the S&P 500 index

Is CRISPR Therapeutics AG in the NASDAQ 100?

No, CRISPR Therapeutics AG is not included in the NASDAQ 100 index

Is CRISPR Therapeutics AG in the Dow Jones?

No, CRISPR Therapeutics AG is not included in the Dow Jones index

When was CRISPR Therapeutics AG's last earnings report?

CRISPR Therapeutics AG's most recent earnings report was on Feb 11, 2025

When does CRISPR Therapeutics AG report earnings?

The next expected earnings date for CRISPR Therapeutics AG is May 8, 2025

Should I buy CRISPR Therapeutics AG stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page